Navigation Links
NASP Announces Jim Smeeding, RPh, MBA, as Executive Director

TAMPA, Fla., April 10, 2013 /PRNewswire-iReach/ -- The National Association of Specialty Pharmacy™ (NASP™) announced the appointment of James E.  Smeeding, RPh, MBA, as the association's first Executive Director. The announcement was made during the NASP Inaugural Specialty Pharmacy Conference, which drew more than 500 participants representing all specialty pharmacy stakeholders. 

"Specialty pharmacy is the fastest growing segment in pharmacy, and we need a strong leader to support NASP's commitment of creating a strong, unified voice for all stakeholders," Gary M. Cohen , BSPharm, RPh, NASP CEO and Co-Founder, said.  "Jim is that leader. He is an experienced, skilled leader who is committed to our core values of improving patient outcomes and fostering a strong environment of collaboration."  

Smeeding, who holds a pharmacy degree from the University of Buffalo and a Masters in Business Administration from the University of Texas, is a well-recognized and widely published leader in the pharmacy industry. He has experience in a variety of areas including hospital pharmacy, clinical services design, home infusion therapy, managed care services and disease management.  Smeeding is the founder of the Center for Pharmacoeconomic Studies at the University of Texas, College of Pharmacy, where he has focused his research on pharmacoeconomics, systems integration and managed care.

"The NASP Board members unanimously felt Jim's previous track record of collaborative and inclusionary leadership in diverse industry roles over the years solidified our belief that he is the right individual to drive the mission of our organization," Burt Zweigenhaft , member of the NASP Board of Directors, said.

During his 40-year career, Smeeding has been instrumental in the development of companies servicing the pharmaceutical industry including the following:

  • The TPG National Payor Roundtable - an educational company that brings product and service offerings to managed care decision makers. 
  • The Jestarx Group - a data and educational resource company that works with pharmaceutical manufacturers in the analysis and presentation of pharmacoeconomic and health outcomes data.
  • Digital Health Dialog a patented patient engagement company utilizing mobile-phone tools that lets users deliver instant, personally targeted messages to patients at more convenient points in their therapy.
  • Project Rx - a service company that works with hospital pharmacies to assess, evaluate and improve quality, safety and efficiency of service delivery.
  • Edjudicate - a private consultancy group that focuses on unique needs of pharmaceutical oriented customers. 

Smeeding's private clients constitute the spectrum of pharmaceutical companies, medical device companies, diagnostic testing and all classes of pharmacy affairs – hospital, retail, chain, managed care, academic and research.  His broad expertise in professional affairs has allowed his clients to understand, approach and impact medical and pharmacy affairs from product selection through to the value proposition as well as professional communications, patient communications and safety.  Jim is widely known for his broad interests and his ability to moderate a program to bring out cogent learning points and make the educational program applicable to practice.

In organizational affairs, Jim held multiple leadership positions within the American Society of Health System Pharmacists (ASHP) and was a founder and president of the International Society of Pharmacoeconmics and Outcomes Research (ISPOR).  His organizational experience and relationships throughout all of pharmacy will allow NASP to forge the collaborative relationships identified within its mission and goals.

"I look forward to the challenge of building partnerships and strengthening collaboration across all channels and practice settings," Smeeding said. "NASP has already made a strong impact and I am honored to work with the Board of Directors to advance our mission and goals.

NASP, founded in 2012, represents specialty pharmacy professionals in all practice settings and highlights the unique value its members bring to patients and the healthcare system. Specialty pharmacy is the fastest growing segment in the industry today and NASP provides valuable benefits to members by creating a strong, unified voice for all stakeholders.

Source: National Association of Specialty Pharmacy (

Media Contact: Gary Cohen ,

Media Contact: Gary Cohen National Association of Specialty Pharmacy, 813-926-5000,

News distributed by PR Newswire iReach:

SOURCE National Association of Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Andain Inc. Announces Successful 510K Tests of its Breakthrough Miniature Disposable Insulin Pump
2. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
3. CryoLife Announces Release Date and Teleconference Call Details for 2013 First Quarter Financial Results
4. Zosano Pharma, Inc. Announces Key Strategic Hire
5. Ingenuity Systems Announces Awardees of Grant Program
6. BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
7. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
8. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
9. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
10. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
11. Uroplasty Announces CEO Resignation
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
Breaking Medicine News(10 mins):